Trial · NCT07410130
Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
NCT07410130, Not yet recruiting, Assiut University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate. Trials, record NCT07410130. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07410130
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
- NCT number
- NCT07410130
- Status
- Not yet recruiting
- Enrollment
- 25 participants, estimated
- Lead sponsor
- Assiut University
- Conditions
- Von Willebrand Disease (VWD), Inherited Bleeding Disorders in Children, Pediatric Hemostatic Disorders
- Interventions
- Tranexamic Acid, Von Willebrand Factor-Containing Concentrates
- First posted
- 2026-02-13
- Last updated
- 2026-02-13
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Frequency of Von Willebrand Disease Among Investigated Children | at enrollment | The proportion of children diagnosed with von Willebrand disease among those evaluated for suspected bleeding disorders at Assiut University Children's Hospital. |
| Primary | Distribution of Von Willebrand Disease Subtypes | Within 2 weeks of enrollment | Classification and relative frequency of von Willebrand disease types (Type 1, Type 2, and Type 3) according to ISTH diagnostic criteria based on laboratory findings. |
| Primary | Clinical Bleeding Patterns in Children With Von Willebrand Disease | at enrollment. | Assessment of bleeding manifestations, including epistaxis, bruising, mucosal bleeding, postsurgical bleeding, and menorrhagia, using standardized clinical evaluation and bleeding assessment tools. |
| Other | Use of Von Willebrand Factor-Containing Concentrates | From enrollment up to 6 months of follow-up | Frequency of administration of VWF-containing concentrates during bleeding episodes or as prophylaxis. |
| Other | Healthcare utilization | Up to 6 months following enrollment | Number of emergency department visits or hospital admissions related to bleeding episodes during the follow-up period. |
| Other | Adverse Events Related to Treatment | From enrollment up to 6 months of follow-up | Occurrence of treatment-related adverse events, including allergic reactions or other reported complications. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07410130
GET https://conductscience.org/api/trials/v1/NCT07410130/registered